patent.fyi
Applications  /  US 2026/0355231
United States Patent Application Publication

US 2026/0355231 A1

Published
Nov 12, 2026
Filed
Jul 21, 2026
Earliest date on the face
Dec 17, 2019
Classification
A61K 33/04
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Rigid glass ampoule

What ifWhat if a rigid, flame-sealed glass ampoule holds the selenium solution?
Claim language“an oxygen impermeable flexible container”

A borosilicate glass ampoule holds a single dose of solution. A flame fuses the glass neck after filling, and the fused neck and glass wall limit oxygen exchange during storage.

1.1Oral tablet in foil

What ifWhat if a foil blister holds a dry selenium tablet for oral use?
Claim language“a solution provided in the oxygen impermeable flexible container”

A sodium selenite premix distributes the selenium dose through a blend of microcrystalline cellulose and a disintegrant before compression. The sealed blister limits moisture uptake, and the tablet breaks apart in gastrointestinal fluid to release soluble selenite.

1.2Selenate in aqueous solution

What ifWhat if dissolved sodium selenate supplies the selenium?
Claim language“selenium compound in the form of Se(IV)”

Sodium selenate dissociates in water into sodium ions and selenate ions, which contain selenium in the +6 oxidation state. The fill volume and the sodium selenate concentration determine the elemental selenium content of each unit.

1.2Dissolved selenomethionine for oral use

What ifWhat if dissolved selenomethionine supplies the selenium in an oral solution?
Claim language“selenium compound in the form of Se(IV)”

Selenomethionine dissolves in the aqueous vehicle with selenium bound within the amino acid. Intestinal amino acid transport systems take up selenomethionine after ingestion.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Selenium premix for animal feed

An oxygen-barrier flexible pouch holds an aqueous sodium selenite premix containing dissolved oxygen. A fill line supplies the premix from a stirred tank and seals the pouch at the fill port. At the feed mill, a metering pump transfers the premix from the pouch into a liquid manifold that sprays it onto feed in a ribbon mixer.

Component substitution

Glass cartridge for selenium concentrate

A rigid borosilicate glass cartridge replaces the flexible container and holds an aqueous sodium selenite solution containing dissolved oxygen. A fluoropolymer-faced elastomer plunger closes the rear of the cartridge, and a crimped septum seals the outlet. A dispensing actuator advances the plunger to transfer the solution through a needle that pierces the septum.

Parameter or scale variation

Two milliliter unit fill pouches

A roll of oxygen-barrier laminate forms a strip of ten independently sealed 2 mL pouches. A positive-displacement filler draws the Se(IV) solution from a closed reservoir and dispenses 2.0 mL per pouch. A heat sealer closes each fill opening, and perforations between the transverse seals let operators detach individual pouches.

Combination with existing systems

Pouch feed for automated nutrition compounding

An oxygen-barrier flexible pouch containing a Se(IV) solution with dissolved oxygen connects to a dedicated inlet on an automated parenteral nutrition compounder. The compounder draws solution through disposable tubing using a peristaltic pump. Its controller stops the pump when the receiving bag gains the mass corresponding to the programmed selenium addition.

Automated or data-driven variant

Feedback control of dissolved oxygen

An optical dissolved oxygen probe measures the Se(IV) solution in a recirculation loop upstream of the pouch filler. A hollow-fiber membrane contactor in the loop exchanges oxygen between the liquid and a gas blend supplied by oxygen and nitrogen mass-flow controllers. A controller adjusts the blend using the measured concentration and enables filling when the reading enters the configured acceptance band.

Optical oxygen measurement after filling

An oxygen-sensitive fluorescent patch sits on the wetted side of a transparent oxygen-barrier laminate panel in each flexible pouch. After sealing, a reader illuminates the patch through the panel and converts its fluorescence lifetime to dissolved oxygen concentration using a temperature-compensated calibration. The line controller records the reading against the pouch identifier and diverts pouches with readings outside the configured acceptance band.

Specific version of a part

Separate storage from reducing ingredients

A vacuum membrane contactor removes dissolved oxygen from the selenite solution before filling, and a peelable seal separates the two chambers during storage. The seal opens during preparation, which limits the time that selenite and ascorbate remain in contact before use.

Dry storage with sealed diluent

A dual-chamber container holds a dry sodium selenite and mannitol cake in one chamber and water with a low dissolved oxygen content in the other. Opening the internal seal releases the diluent onto the cake, and mixing produces the solution just before use.

Foil laminate flexible pouch

A flexible laminate surrounds an aluminum foil barrier with a polypropylene liquid-contact layer and an outer polyester layer. Heat seals join the polypropylene faces around the perimeter, and a sealed port provides access to the solution.

Collapsible pouch with welded port

Two flexible barrier-film panels enclose the liquid, and a weld joins the polymer port flange to the pouch wall. The pouch collapses as the solution leaves through the port, so dispensing requires no air inlet.

Sodium selenite with controlled oxygen

Sodium selenite dissolves in water to provide selenium in the +4 oxidation state. A membrane contactor equilibrates the solution with an oxygen and nitrogen mixture, and a temperature-compensated optical probe checks a dissolved oxygen target of 2 ppm before filling.

Selenous acid with dissolved oxygen

Selenous acid supplies selenium in the +4 oxidation state, and the solution pH determines the distribution between molecular selenous acid and its dissociated forms. Filtered air supplies oxygen through a membrane contactor, and an inline probe measures dissolved oxygen before transfer to the filling line.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2013/0207058 A1
Published
Aug 15, 2013
Filed
Aug 13, 2012
Class
C03C 4/10
Document BUS 2014/0303254 A1
Published
Oct 9, 2014
Filed
Apr 5, 2014
Class
B65B 55/14
Claim 1
Document A
Document B
1.1an oxygen impermeable flexible container and further comprising a solution provided in the oxygen impermeable flexible container
In an embodiment, the flexible infusion bag 201 is overwrapped within one or more overwraps 202 prior to sterilization of the oxidation susceptible drug solution in the flexible infusion bag 201. In an embodiment, the overwrap 202 is a barrier layer configured to reduce or preclude permeation of oxygen to the oxidation susceptible drug solution contained within the flexible infusion bag 201 during or after sterilization.
B · US 2014/0303254 A1 · ¶ 47
1.2wherein the solution comprises at least one selenium compound in the form of Se(IV) selected from the group consisting of sodium selenite, selenous acid and selenium dioxide, and wherein the solution comprises dissolved oxygen (DO).
Especially preferably, the oxygen containing selenium compound is selected from selenium dioxide (SeO2), sodium selenite (Na2SeO3) and mixtures thereof.
A · US 2013/0207058 A1 · ¶ 28

An empty cell means only that no passage was reproduced there.

Statements in these documents
The glasses of the present disclosure are free of disturbing shades of yellow or brown, which often occur with the production of titanium oxide containing glass compositions, when no arsenic and antimony compounds are used as refining agents.
A · US 2013/0207058 A1 · ¶ 4
The glasses according to the present disclosure are particularly suitable as raw material for the production of infrared (IR) light conductors, cover glasses for photo sensors, ultraviolet (UV) filter glasses or the like.
A · US 2013/0207058 A1 · ¶ 5
The drug product disclosed herein relates to a stable, ready to use parenteral drug product prepared by moist heat sterilization of a drug solution comprising an active pharmaceutical ingredient in a flexible infusion bag, wherein the active pharmaceutical ingredient in the drug product is susceptible to oxidation by ambient oxygen, light, or moisture.
B · US 2014/0303254 A1 · ¶ 2
While formulating acetaminophen in pharmaceuticals, it is desirable to keep the pH of the medium between about 5 to about 6 to maximize the shelf life for the product.
B · US 2014/0303254 A1 · ¶ 8
Cite aspatent.fyi, US 2026/0355231 A1, claim 1, first published 2026-11-19T09:44:02-05:00, https://patent.fyi/US20260355231/, SHA-256 08b2d9b7f59f7d2f1d939c24a4fbdb47eca9ee8ae4f30094adea5577634b83cd
First published
Permanent addresshttps://patent.fyi/US20260355231/
Content fingerprint (SHA-256)08b2d9b7f59f7d2f1d939c24a4fbdb47eca9ee8ae4f30094adea5577634b83cd
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi